TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.
Clinical trial NCT02653209 · COMPLETED
Trial details
- NCT number
- NCT02653209
- Sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2021-01-01
- Enrollment
- 525
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.